VOICED : Tras 20 meses de restricciones, el lunes EEUU reabre sus fronteras

VOICED : Tras 20 meses de restricciones, el lunes EEUU reabre sus fronteras

Assessment

Interactive Video

Social Studies, Business

9th - 12th Grade

Hard

Created by

Quizizz Content

FREE Resource

The United States is reopening its borders to vaccinated travelers after 20 months of COVID-19 restrictions. This decision, criticized by Europe, Mexico, and Canada, has separated families and disrupted commerce. Alison Henry, a British citizen, shares her personal story of missing significant family events. The reopening is expected to boost the struggling aviation sector and border economies. Travelers from over 30 countries can enter, but must present a negative COVID-19 test and vaccination proof. Accepted vaccines include those approved by the WHO, excluding Sputnik V and CanSino.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was one of the main criticisms of the U.S. border closure?

It was not enforced strictly.

It allowed too many exceptions.

It was too short.

It separated families and disrupted businesses.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How did the border closure affect Alison Henry?

She missed her daughter's wedding.

She couldn't visit her son in the U.S.

She was unable to travel to Europe.

She lost her job.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is expected to benefit from the reopening of the U.S. borders?

The education sector.

The aviation industry and border cities.

The tourism sector in Europe.

The technology sector.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is required for travelers entering the U.S. after the reopening?

A negative COVID test and a vaccination certificate.

A quarantine period and a health declaration.

A visa and a travel insurance.

A letter of invitation and a health check.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccines are not accepted by the U.S. for entry?

Sputnik V and CanSino.

Sinopharm and Sinovac.

AstraZeneca and Johnson & Johnson.

Pfizer-BioNTech and Moderna.